Serum markers of acute sarcoidosis.

V. Evstifeev (Moscow, Russian Federation), E. Adamovskaya (Moscow, Russian Federation), G. Shepelkova (Moscow, Russian Federation), A. Zaytseva (Moscow, Russian Federation), E. Shmelev (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation)

Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Session: Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases
Session type: E-poster session
Number: 1091
Disease area: Interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
V. Evstifeev (Moscow, Russian Federation), E. Adamovskaya (Moscow, Russian Federation), G. Shepelkova (Moscow, Russian Federation), A. Zaytseva (Moscow, Russian Federation), E. Shmelev (Moscow, Russian Federation), V. Yeremeev (Moscow, Russian Federation). Serum markers of acute sarcoidosis.. 1091

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Serum markers of IPF
Source: Research Seminar 2004 - Genotyping and Phenotyping of Diffuse Parenchymal Lung Diseases
Year: 2004


Elevated circulating concentrations of adiponectin in sarcoidosis – a new marker of disease?
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


Elevated serum inflammatory markers in patients with stable COPD
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Serum C-reactive protein concentrations in patients with sarcoidosis: can be taken this simple test as an activation marker in sarcoidosis?
Source: Eur Respir J 2004; 24: Suppl. 48, 712s
Year: 2004

Prognostic significance of serum markers in acute exacerbation of idiopathic interstitial pneumonias
Source: Annual Congress 2011 - Clinical perspectives in several interstitial diseases
Year: 2011

Serum chitotriosidase levels in granulomatous lung disorders
Source: Annual Congress 2006 - Clinical features and disease markers of sarcoidosis
Year: 2006


Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD
Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease
Year: 2009


Serum magnesium levels in acute exacerbation of COPD
Source: Annual Congress 2007 - Exacerbations of COPD
Year: 2007


Increased serum endotoxin levels as biomarker in acute exacerbations of COPD.
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018

The evaluation of serum biomarkers in patients with sarcoidosis: Can visfatin be a new biomarker for sarcoidosis?
Source: International Congress 2017 – Rare diseases
Year: 2017


Serum neopterin and IL-6 as biomarkers in patients with COPD.
Source: International Congress 2017 – Novel molecular and genetic targets in COPD
Year: 2017


Serum KL-6 identifies ILD patients with a progressive fibrosing phenotype
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD
Source: Annual Congress 2005 - Acute and chronic infections in COPD
Year: 2005


Serum KL-6 as a marker of disease progression in SSc-ILD
Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside
Year: 2018




Serum levels of chitotriosidase in pulmunary sarcoidosis
Source: Annual Congress 2008 - COPD and other environment-related lung diseases
Year: 2008

Serum TNFα and IL8 as markers of systemic inflammation in severe asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 279s
Year: 2005

Serum interleukin 18 as a monitoring marker of long clinical course of pulmonary sarcoidosis
Source: Eur Respir J 2004; 24: Suppl. 48, 711s
Year: 2004

Usefulness of inflammatory markers: procalcitonin, neopterin, C-reactive protein and MR-proANP in the follow-up of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2008 - Biomarkers and antibiotic treatment of exacerbations of COPD
Year: 2008


Serum KL-6 and SP-D as useful clinical indicators of interstitial changes and pulmonary functional abnormality in patients with Sjogren's syndrome
Source: Eur Respir J 2001; 18: Suppl. 33, 367s
Year: 2001

Serum KL-6 elevation related with severity in patients with pneumocystis pneumonia
Source: Annual Congress 2011 - Infection in the immunocompromised host: infrequent aetiologies
Year: 2011